tirzepatide is insulin for diabetes: on track to SURPASS current therapy Tirzepatide (Mounjaro): Type 2 Diabetes

2023 Mar 27;14:1121387

It's the first medication of its kind to work on two appetite hormones at once, which is part of the reason patients on the highest dose lost an average of 22.5% of their body weight over 72 weeks in clinical trials

Like similar drugs, its used as a shot patients give themselves once a week and is recommended on top of a reduced-calorie diet and increased exercise

A reduction in body weight was observed with ZEPBOUND irrespective of age, sex, race, ethnicity, baseline BMI, and glycemic status

SeekPeptides provides detailed comparison guides for every major GLP-1 medication, helping you understand the differences in pharmacology, side effects, and dosing requirements so you can make informed decisions about your research protocol

This effect is complementary to the action on the GLP-1 receptor